Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online January 26, 2007
Diabetes Care 30:1143-1149, 2007
DOI: 10.2337/dc06-1809
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-1809v1
30/5/1143    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beysen, C.
Right arrow Articles by Hellerstein, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beysen, C.
Right arrow Articles by Hellerstein, M. K.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Article

Whole-Body Glycolysis Measured by the Deuterated-Glucose Disposal Test Correlates Highly With Insulin Resistance In Vivo

Carine Beysen, DPHIL1, Elizabeth J. Murphy, MD, DPHIL1,2, Tracey McLaughlin, MD3, Timothy Riiff, BS, MSE1, Cindy Lamendola, BA3, Holly C. Turner, BS1, Mohamad Awada, PHD1, Scott M. Turner, PHD1, Gerald Reaven, MD3 and Marc K. Hellerstein, MD, PHD2,4

1 KineMed, Inc., Emeryville, California
2 San Francisco General Hospital, University of California at San Francisco, San Francisco, California
3 Stanford University, Palo Alto, California
4 Nutritional Sciences and Toxicology, University of California at Berkeley, California

Address correspondence and reprint requests to Marc Hellerstein, MD, PhD, Nutritional Sciences and Toxicology, 309 Morgan Hall, University of California at Berkeley, Berkeley, CA 94720. E-mail: march{at}nature.berkeley.edu

OBJECTIVE—The purpose of this study was to compare an in vivo test of whole-body glycolysis, the deuterated-glucose disposal test (2H-GDT), with insulin sensitivity measured by the euglycemic-hyperinsulinemic glucose clamp and the steady-state plasma glucose (SSPG) test.

RESEARCH DESIGN AND METHODS—The 2H-GDT consists of an oral glucose challenge containing deuterated glucose, followed by measurement of heavy water (2H2O) production, which represents whole-body glycolytic disposal of the glucose load. 2H2O production is corrected for ambient insulin concentration as an index of tissue insulin sensitivity. The 2H-GDT was compared with euglycemic-hyperinsulinemic glucose clamps in healthy lean subjects (n = 8) and subjects with the metabolic syndrome (n = 9) and with the SSPG test in overweight (n = 12) and obese (n = 6) subjects.

RESULTS—A strong correlation with the clamp was observed for the 75-g and 30-g 2H-GDT (r = 0.95, P < 0.0001 and r = 0.88, P < 0.0001, respectively). The 2H-GDT and clamp studies revealed marked insulin resistance in subjects with metabolic syndrome compared with lean control subjects. The correlation with the clamp was maintained in each group (lean, r = 0.86, P < 0.01; metabolic syndrome, r = 0.81, P < 0.01) for the 75-g test. The 2H-GDT also correlated strongly with the SSPG test (r = –0.87, P < 0.0001) in overweight and obese subjects.

CONCLUSIONS—The 2H-GDT, which measures whole-body glycolysis in humans in a quantitative manner, correlates highly with the euglycemic-hyperinsulinemic glucose clamp and the SSPG test. Impaired insulin-mediated whole-body glycolysis is a feature of insulin resistance, which provides a means of assessing insulin sensitivity in vivo.

Abbreviations: AUC, area under the curve • EGP, endogenous glucose production • 2H-GDT, deuterated-glucose disposal test • HOMA, homeostasis model assessment • IR-MS, isotope ratio-mass spectrometry • QUICKI, quantitative insulin sensitivity check index • SSPG, steady-state plasma glucose • TBW, total body water


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. K. Hellerstein
Exploiting Complexity and the Robustness of Network Architecture for Drug Discovery
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 1 - 9.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
U. Schweiger, W. Greggersen, S. Rudolf, M. Pusch, T. Menzel, S. Winn, J. Hassfurth, E. Fassbinder, K. G. Kahl, K. M. Oltmanns, et al.
Disturbed Glucose Disposal in Patients With Major Depression; Application of the Glucose Clamp Technique
Psychosom Med, February 1, 2008; 70(2): 170 - 176.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.